EKF Diagnostics Holdings (LSE:EKF) 3-Month Share Buyback Ratio: 0.00% (As of Jun. 2026 )

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

LSE:EKF EKF Diagnostics Holdings PLC LSE:EKF
40 GF Score
Price £0.26
GF Value £0.29
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is EKF Diagnostics Holdings 3-Month Share Buyback Ratio?

EKF Diagnostics Holdings LSE:EKF +1.17% 40 3-Month Share Buyback Ratio is 0.00 as of Jun. 2026. GuruFocus rates LSE:EKF with a GF Score™ of 40/100 and a GF Value™ of £0.29 (Modestly Undervalued). The stock has 4 warning signs investors should review.

3-Month Share Buyback Ratio only apply to companies whose reporting frequency is 3 months.

LSE:EKF
40GF Score
EKF Diagnostics Holdings PLC LSE:EKF
3-Month Share Buyback Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a 3-Month Share Buyback Ratio of 0.00 mean?
EKF Diagnostics Holdings (LSE:EKF) has a 3-Month Share Buyback Ratio of 0.00 as of Jun. 2026. The 3-Month Share Buyback Ratio measures the proportion of a company's outstanding shares repurchased over the past three months, calculated as the percentage change in shares outstanding from the previous quarter to the current quarter. View historical data for EKF Diagnostics Holdings and its competitors.
Is EKF Diagnostics Holdings' 3-Month Share Buyback Ratio too high?
EKF Diagnostics Holdings' current 3-Month Share Buyback Ratio is 0.00. Overall, EKF Diagnostics Holdings has a GF Score™ of 40/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does EKF Diagnostics Holdings' 3-Month Share Buyback Ratio compare to ABT and SYK?
EKF Diagnostics Holdings' 3-Month Share Buyback Ratio of 0.00 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Month Share Buyback Ratio for a Medical Devices & Instruments company?
A good 3-Month Share Buyback Ratio depends on the Medical Devices & Instruments industry context. However, 3-Month Share Buyback Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Month Share Buyback Ratio mean?
A high 3-Month Share Buyback Ratio can signal that a stock is expensive relative to its fundamentals. The 3-Month Share Buyback Ratio measures the proportion of a company's outstanding shares repurchased over the past three months, calculated as the percentage change in shares outstanding from the previous quarter to the current quarter. View historical data for EKF Diagnostics Holdings and its competitors. EKF Diagnostics Holdings's current 3-Month Share Buyback Ratio is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is EKF Diagnostics Holdings stock overvalued right now?
Based on GuruFocus' analysis, EKF Diagnostics Holdings (LSE:EKF) is currently considered Modestly Undervalued. The stock's GF Value™ is £0.29, compared to a current price of £0.26 — trading 10.3% below its estimated fair value. The current 3-Month Share Buyback Ratio is 0.00. EKF Diagnostics Holdings' overall GF Score™ is 40/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Month Share Buyback Ratio calculated?
3-Month Share Buyback Ratio is calculated from a company's financial statements. For EKF Diagnostics Holdings (LSE:EKF), the current 3-Month Share Buyback Ratio is 0.00 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is EKF Diagnostics Holdings (LSE:EKF) Overvalued in 2026?

Based on GuruFocus' analysis, EKF Diagnostics Holdings stock appears to be undervalued. The current stock price of £0.26 is trading 10.3% below its estimated GF Value™ of £0.29. GuruFocus considers EKF Diagnostics Holdings to be Modestly Undervalued.

Key valuation signals for LSE:EKF:

  • 3-Month Share Buyback Ratio: 0.00
  • GF Value™: £0.29 vs. price of £0.26 (10.3% below fair value)
  • GF Score™: 40/100 with 4 warning signs

No single metric tells the full story. See the LSE:EKF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

EKF Diagnostics Holdings Business Description

Other Exchanges EKDHF:USALYF:Germany
Address 19 Stanwell Road, Avon House, Penarth, Cardiff, GBR, CF64 2EZ
EKF Diagnostics Holdings PLC is engaged in development, manufacture and supply of products and services into the in-vitro diagnostic (IVD) market place. The Group has presence in the UK, USA, Germany, and Russia, and sells throughout the world including Europe, the Middle East, the Americas, Asia, and Africa. It derive their revenue from the manufacture and sale of medical diagnostic equipment and reagents. Other services include the servicing and distribution of third party company products under separate distribution agreements.
40GF Score

Get the complete analysis for LSE:EKF

3-Month Share Buyback Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

£0.26
Price
£0.29
GF Value